位置:首页 > 蛋白库 > NRPS_CURCL
NRPS_CURCL
ID   NRPS_CURCL              Reviewed;       13041 AA.
AC   A0A348AXX4;
DT   12-AUG-2020, integrated into UniProtKB/Swiss-Prot.
DT   07-NOV-2018, sequence version 1.
DT   03-AUG-2022, entry version 14.
DE   RecName: Full=Nonribosomal peptide synthetase {ECO:0000303|PubMed:29686660};
DE            Short=NRPS {ECO:0000303|PubMed:29686660};
DE            EC=2.1.1.- {ECO:0000305|PubMed:29686660};
DE            EC=6.3.2.- {ECO:0000305|PubMed:29686660};
DE   AltName: Full=KK-1 biosynthesis cluster protein NRPS {ECO:0000303|PubMed:29686660};
GN   Name=NRPS {ECO:0000303|PubMed:29686660}; ORFNames=TRAF135001;
OS   Curvularia clavata.
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Dothideomycetes;
OC   Pleosporomycetidae; Pleosporales; Pleosporineae; Pleosporaceae; Curvularia.
OX   NCBI_TaxID=95742;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RC   STRAIN=BAUA-2787;
RX   PubMed=29686660; DOI=10.3389/fmicb.2018.00690;
RA   Yoshimi A., Yamaguchi S., Fujioka T., Kawai K., Gomi K., Machida M.,
RA   Abe K.;
RT   "Heterologous Production of a Novel Cyclic Peptide Compound, KK-1, in
RT   Aspergillus oryzae.";
RL   Front. Microbiol. 9:690-690(2018).
CC   -!- FUNCTION: Nonribosomal peptide synthetase; part of the gene cluster
CC       that mediates the biosynthesis of KK-1, a novel cyclic decapeptide
CC       compound with potent antifungal activity (PubMed:29686660). The
CC       nonribosomal peptide synthetase (NRPS) catalyzes the elongation and
CC       cyclization of the decapeptide chain composed of 1 pipecolic acid
CC       residue (Pip), 1 alanine residue (Ala), 1 aspartic acid residue (Asp),
CC       1 isoleucine residue (Ile), 1 glycine residue (Gly), 1 tyrosine residue
CC       (Tyr) and 4 valine residues (Val) (PubMed:29686660). The Asp, Ile and 3
CC       Val residues are N-methylated by the 5 methyltransferase domains from
CC       the NRPS (found in modules 3, 5, 6, 7 and 9), whereas the Tyr residue
CC       is O-methylated, probably by the cluster encoded O-methyltransferase
CC       OMT (PubMed:29686660). The other tailoring enzymes from the cluster may
CC       be involved in further modifications leading to the synthesis of KK-1
CC       (Probable). {ECO:0000269|PubMed:29686660, ECO:0000305|PubMed:29686660}.
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000305|PubMed:29686660}.
CC   -!- DOMAIN: NRP synthetases are composed of discrete domains (adenylation
CC       (A), thiolation (T) or peptidyl carrier protein (PCP) and condensation
CC       (C) domains) which when grouped together are referred to as a single
CC       module. Each module is responsible for the recognition (via the A
CC       domain) and incorporation of a single amino acid into the growing
CC       peptide product. Thus, an NRP synthetase is generally composed of one
CC       or more modules and can terminate in a thioesterase domain (TE) that
CC       releases the newly synthesized peptide from the enzyme. Occasionally,
CC       methyltransferase domains (responsible for amino acid methylation) are
CC       present within the NRP synthetaseTES has the following 10 modules
CC       architecture: A1-T1-C1-A2-T2-C2-A3-M3-T3-C3-A4-T4-C4-A5-M5-T5-C5-A6-M6-
CC       T6-C6-A7-M7-T7-C7-A8-T8-C8-A9-M9-T9-C9-A10-T10-C10.
CC       {ECO:0000305|PubMed:29686660}.
CC   -!- SIMILARITY: Belongs to the NRP synthetase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; LC371755; BBC83957.1; -; Genomic_DNA.
DR   GO; GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0043604; P:amide biosynthetic process; IEA:UniProt.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   GO; GO:1901566; P:organonitrogen compound biosynthetic process; IEA:UniProt.
DR   Gene3D; 1.10.1200.10; -; 9.
DR   Gene3D; 3.30.300.30; -; 15.
DR   Gene3D; 3.30.559.10; -; 10.
DR   Gene3D; 3.40.50.12780; -; 2.
DR   Gene3D; 3.40.50.150; -; 5.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR010071; AA_adenyl_domain.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR025110; AMP-bd_C.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; ANL_N_sf.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001242; Condensatn.
DR   InterPro; IPR041698; Methyltransf_25.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   Pfam; PF00501; AMP-binding; 10.
DR   Pfam; PF13193; AMP-binding_C; 4.
DR   Pfam; PF00668; Condensation; 10.
DR   Pfam; PF13649; Methyltransf_25; 1.
DR   Pfam; PF00550; PP-binding; 10.
DR   SMART; SM00823; PKS_PP; 10.
DR   SUPFAM; SSF47336; SSF47336; 10.
DR   SUPFAM; SSF53335; SSF53335; 5.
DR   TIGRFAMs; TIGR01733; AA-adenyl-dom; 9.
DR   PROSITE; PS00455; AMP_BINDING; 10.
DR   PROSITE; PS50075; CARRIER; 10.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 6.
PE   1: Evidence at protein level;
KW   Isomerase; Ligase; Methyltransferase; Multifunctional enzyme;
KW   Phosphopantetheine; Phosphoprotein; Repeat; S-adenosyl-L-methionine;
KW   Transferase.
FT   CHAIN           1..13041
FT                   /note="Nonribosomal peptide synthetase"
FT                   /id="PRO_0000450430"
FT   DOMAIN          788..864
FT                   /note="Carrier 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          1865..1939
FT                   /note="Carrier 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          3353..3427
FT                   /note="Carrier 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          4412..4486
FT                   /note="Carrier 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          5897..5971
FT                   /note="Carrier 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          7386..7460
FT                   /note="Carrier 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          8871..8945
FT                   /note="Carrier 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          9943..10017
FT                   /note="Carrier 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          11428..11502
FT                   /note="Carrier 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          12495..12569
FT                   /note="Carrier 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   REGION          267..663
FT                   /note="Adenylation 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          882..1313
FT                   /note="Condensation 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          1341..1736
FT                   /note="Adenylation 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          1957..2383
FT                   /note="Condensation 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          2418..2812
FT                   /note="Adenylation 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          2891..3023
FT                   /note="Methyltransferase (M) domain 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          3445..3869
FT                   /note="Condensation 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          3901..4300
FT                   /note="Adenylation 4"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          4504..4935
FT                   /note="Condensation 4"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          4963..5362
FT                   /note="Adenylation 5"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          5430..5567
FT                   /note="Methyltransferase (M) domain 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          5989..6416
FT                   /note="Condensation 5"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          6451..6845
FT                   /note="Adenylation 6"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          6924..7056
FT                   /note="Methyltransferase (M) domain 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          7478..7901
FT                   /note="Condensation 6"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          7934..8335
FT                   /note="Adenylation 7"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          8404..8540
FT                   /note="Methyltransferase (M) domain 4"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          8963..9392
FT                   /note="Condensation 7"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          9422..9822
FT                   /note="Adenylation 8"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          10035..10462
FT                   /note="Condensation 8"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          10494..10892
FT                   /note="Adenylation 9"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          10959..11105
FT                   /note="Methyltransferase (M) domain 5"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          11520..11945
FT                   /note="Condensation 9"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          11977..12377
FT                   /note="Adenylation 10"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   REGION          12647..13032
FT                   /note="Condensation 10"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29686660"
FT   MOD_RES         825
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         1899
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         3387
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         4446
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         5931
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         7420
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         8905
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         9977
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         11462
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         12529
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   13041 AA;  1442979 MW;  7B7033EBAC8C5A63 CRC64;
     MASDINTHPE GATKFWQQHF DGLNASVFPA LSSHLTVPRP NAQTAHRISY STLAKQKWDN
     TSLCRAALAI LLARYSNASE ALFGVLVEQF LPSNGEQAST EESPQSILPI RIRLDLEEAG
     LGLLQAINTL DASLREWKHI GLDAIRGTGE YGSAGCEFQT VLAVTTGKTP RTHRLASCTD
     RALLLDCRMD DDSATLLARY DPSVIDDLQV ARFLKQLGHV IEQLRVQAVD LPLWELGIVT
     QEDSAEIQKW NSQQLQFSQE CIHDVFANRV VDTPQKIAVS AWNGELTFAE LDSFSSCLAQ
     HIQSLELGDA KAIPLCFEKS KWAIVGMLGV LKAGRAFTLI DPSNPPARAR QICRQTAATI
     SIASPYQCDM MRALVPDCIV VDDDFFKSLA FDTDQFQPTA TPQTLAYILF TSGSTGEPKG
     SMMEHHGFVS CCLEFGAALG INSNTRALQF ASYAFGACLL EILTTLMHGG TVCIPSDDER
     INDAPGFIRR ANVNWAILTP SFIGAIQPTT VPNLKTLVLV GEAMPSDIRD VWASHVQLKN
     AYGQSESATI CSVTEVTPAT VEAHNIGHAV GARFWITDPN NPNKLAPIGC VGELLVESPG
     IARGYLIPLP ADATPFIDTL PDWYPRTQPL DNFKFYRTGD LVCYRSDGTV VYLGRRDSQI
     KIRGQRVEIG EVETCLRQQL PSQLVPVVEA VSLSGMSKSM TLIAFLVGEN TILEEDVYVL
     EGSAAQRISS KLRQIVPGYC IPSHYIRINH LPTTATGKCD RKALRAIGTK LLREAVEGMA
     SQEEQESASL MTEGITLERI WFQSLGLKPN STRHKSNFFN LGGDSIAAIR MVNMARAAGL
     LLSISDIFQN PSLAGLINVM QQSSTAQDAI PATEYSGPVE QSFAQGRLWF LDQLTTGASW
     YLMPLAVRIH GPLRVQALSS ALHALEQRHE TLRTTFEQQD GMGVQIVHPS SKRELRVIDV
     SGKQNGGYDQ VLKREQTTPI DLAKEPGWRA ALLRVGDDEH ILSIVIHHII YDGWSLGVLR
     EELGDLYAAA LRGPDPLAHM APLPIQYRDF SVWQKQPQQV AQHQQQLVYW TKQLEDSAPA
     ELLTDFPRPA ELSGRAGEVR FTIEGSVFDS LLAFRRVHQT TSFAVLLAVF RAAHYRLTGT
     EDATIGTPIA NRTRAEVEKL IGFFVNTQCM RIAVADDDTF ASLVSQVWSV ATAAFEHQDV
     PFERIVSALL PGARDTSRNP LAQLLFALHL EQDLDKINLE GLACETVPTP MATRFDVEFH
     LFQEDDRLNG VVNFSTDLFE PQTIHSLVSV FQEILRRGLD QPQTPIAHLQ LTDGLEELRN
     AGLLDIKRID YPREASVVDM FQKQVAACPN VTAVKDSTSQ LTYAQLDQES DKIAVWLRKR
     NIPAETLIAL LAPRSCDSVA AFLGILKANL AYLPLDVNVP AARIEAILST VAGHKLVLLG
     RDVPLLGTQL ADLELVRIGE ALRGSSSGSV AADKAIRPTA TSLAYVIFTS GSTGQPKGIM
     VPHRSLVNVI KQRPAYGNVA HMTNLAFDPS LFEMCTALFN GNTLICIDTL VALDATQLPT
     IFKQEAIRVA MMTPALLTRL LAQATDALHE LEALYVLGDR FPPKDAARAS ELVKTAVYNA
     YGPSENSICT TLFHAATGAM CTNGVPVGRV INNSGVYVMD PKQSLVSYGV MGELVVAGEG
     LAIGYTKPEL NEGRFLTLTM DGKPVRAFRT GDRVRYRPTD GQLEFFGRMD FQIKIRGHRV
     ELAEVERVLN RHPAIKDAIT LLRQHGSSAQ DTELVSFIVL GEQKPVKPHR NATDHGGMEI
     EQLDQKLEAN LRAMMQATLP SYMVPSRIIV LDHMPLDKNG KVDRRGLTGL TLSPAMETSS
     RVVVAARNEI EAVLCEEFAH ILGVEIGVTD NFFDLGGHSL MATTLAARLA RRLNASISVK
     DVFDQPIVAN LAATIKRGST PHNAIPPTKY SGPVEQSFAQ GRLWFLDQLN LGAAWYHMPL
     AVRLRGPLHL EALTAALHAL EERHETLRTV FEEQDGVGMQ IVRPSSKTPL RIIDVSTKER
     GYAELLKQEQ TTPFDLATEL GWRVALLRQG KDDHILSIVI HHIISDGWSL DILCEELGQF
     YAAVLRGQDP LAQISPLPIQ YRDFSLWQKQ PEQVAEHHRQ LEYWTTQLEG SVPAELLTDL
     PRPTIQSGKA GVIPITVNGP VYERLRAFSR AHQTTAFAVL LAAFRATHYR LSGVADATIG
     TPIANRNRPE LENMIGFFVN AQCMRITVEQ DDTFETLVRQ IRFTATAAFA NQDVPFEHIV
     SALMPDSRDT SRNPLVQLMF ALHAYKDLGK IELEGYVAEP VHTTLSTRFD LEFHMFQETN
     HLSGYVLYAT DLFEPESIEG MVSIFKEILA RALDQPQTPL ALLPLTDGLA ELRRRGLLEI
     ERPSYPRESS VVDVFCSQVA ASPNATAVKD SISQLTYAQL NEQSDKVAAW LHQCNLPTET
     LVAVLAPRSC QTVVAFLGIL KANLAYLPLD VNVPAARIEA ILSEVSGHIL VLLGSHVSAP
     KIELADVEFV KIDNTVEHNL PGRIGSAPSA TSLAYVIFTS GSTGKPKGVK VEHRGIVRLV
     KESNVVAKMP QAARIAHLSN IAFDAATWEL YAALLNGGTL VCINYLTTLD SKALEAVFEQ
     EKIQAAMLPP ALLKQYLVNI PAAIGALEVV LVAGDRFDRR DAAATQALVG AGVYNAYGPT
     ENTTLSTIYN VVQGDANVNG VPIGRPVSNS GAYIMNMNQE LVPIGVIGEL VVVGDGVARG
     YTDPALDVNR FVNVTIEGQT MRAYRTGDRA RYRPKDAQIE FFGRMDQQIK IRGHRIEPAE
     VEHALLNNDL LQDAAVIIRK QQNDELEMVA FVEANSNKSI EQEASNQVED WGAQFESNVY
     AEIEAIDASA VGNDFMGWTS MYDGSAIDKA EMQEWLDDTM QTILDGRPAG RVLEIGTGTG
     MILFNLGEGL QSYVGLEPST SAAAFVNRRI QTLPAFAGKA EVHVGTATDI SQLQDLRPEV
     VVINSVAQYF PSPEYLSKVL YALAQIPGVK RLFFGDMRSY AINDQFLAAR ALHNIGSKAT
     KSAIRSKMVD LENSEEELLV DPTFFTNLAT ELPEVEHVEI LPKRMQATNE LSAYRYAAVV
     HIRDSSERAQ TVHAIKSSAW VDFSKSQMDR KALISLLQSS VNTEAVAIGN IPYSKTIMAR
     HVVQSLDEDN ADKDIAQDKP DKPTWISAVR SNAEHCPSLS ALDLVQLGEE AGFCVELSWA
     QQRSHHGAID AVFHHYQPAR EGSRVLFQFP TDTYRRQSGP LTNRPLQRIQ SRRMETQVRE
     KLRAVLPSYM IPSLIVLVDQ MPLNPNGKVD RKALERRAQA VLRVEKPTSE RVGARNETEA
     VLCEEFTDVL GLEVGITDNF FDLGGHSLMA TKLAARISRR LDARVSVKDV FDQPVIVDLA
     ASIRRGSTPH NPITPTEYSG PVEQSFAQGR LWFLDQLNLG ASLYLMPLAL RLRGPLRIDA
     LTAALFALEQ RHETLRTVFK EQDGVGIQII QPSQKKKLRT IDVSAGDFSE ALHHERTAPF
     DLASEPGFRV ALLQLEPSDH VLSIVMHHII YDGWSIDILC QELGQFYAAA IQGQDPLGQV
     SPLPIQYRDF SVWQKQPEQV AEHERQLAYW IDQLADSAPA EFLVDLPRPP VLSGDAGLVH
     LTIDGPIYDR LRAFCRVHQT TTFAVLLAAF RATHYRLTGA EDATVGTPIA NRNRPELENL
     VGFFVNTQCM RISVGDDDTF EQLVRQVRST ATAAFANQDV PFERIVSTLL PGSRDTARNP
     LVQLMFAVHS LKDLGKIQFE GLVGETIPTA SFTRFDVEFH LFQEVGRLSG NVLFSTDLFE
     PETIQGMVSV FMEILRGALD QPQIPIAVLP LTDGLTELRN RGLLEVEQPQ YPRDSSVIDV
     FRAQVVACPD AIAVKDSTSQ LTYAQLDEQS DEVAVWLHQR KLPAESLVAV LAPRSCETII
     TFFGILKANL AYLPLDINVP AARIQAILSS VAGKKILLLG SDQAQPEIRL DDVEFVQINE
     TIDHNMAKDN TTRSGPLATS LAYVIFTSGS TGQPKGVKVE HRGIVRLVKN SNVVAKMPEA
     ACVAHLSNLA FDAATWEIYA ALLNGGSLIC IDYFTTLDSK VLEAVFEREQ IRAAMFPPAL
     LKQCLLNIPT TISALDVILA AGDRFDRRDA IAAQALVGGG VYNAYGPTEN TTLSTIYNVV
     DGDTNVNGIP IGLPVSNSGV YVMDPNQQLV PLGVMGELVV VGDGVARGYT DPALDVDRFI
     KVEIDGQIVR AYRTGDRVRH RPKDGQIEFF GRMDQQVKIR GHRIELAEVE HVILDNSLVQ
     DAAVIVHKQA DQEIEMIAFA IVRGDNDSKH PEKDILDRVK ALLPSYMVPA QMVLLNSMPL
     NANGKVDRKE LAKRAGTVPR SEMAYVAPER VPPRNEIETI LCEEYAEVLG VEVGVMDNFF
     DLGGHSLMAT KLAARATRRL DAKLSVKDIF DYPILANLAA AVQRGSTPHN AILATTYSGP
     VEQSFAQGRL WFLDQLNVGS NWYLQPIAIR IRGSLNINAL TTALHALEQR HETLRTTFEE
     EDGVGMQVVQ EYDPIELRIM DIAADYDGDY TEALKGEQTT PFDLESEPGW RVSLLRMNDN
     DHILSLVLHH IISDGWSVDV LRQELKQFYA AALQGLDPLS GADPLPIQYR DFSLWQKQPE
     QVAEHERQLK YWVEQLADNS PATLLADRPR PSVLSGQAGS VPLSIEGQVY EKLQAFCRAH
     QTTSFSVLLA AFRAAHFRLT GVDDATIGIP IANRNRPELE HLIGFFVNRQ CMRITVGEDD
     TFESLIRQVH STATAAYANQ DVPFERIVSS LLSGSRDTSR NPLVQLVFAV HSQKNLGKFE
     LQDLTSEPVA GAISTRFDAE FHLFQEEERL NGVVYYATDL FDAETIQGVV SVFQEILRRG
     LNHPRTPIAA LSLTDGLDNL RKMNLVHFKR TDYPRDSSMV DIFREQVATY PDVIAVKDST
     LQLTYAQLDQ QSDEIATWLR NKKMAPETLV GVLAPRSCQT IVAFLGVLKA NLAYLPLDVN
     APMARVETIM SSVPGSKLLL LGSDVPAQEI QLQNVELVRI EDTLGHAASA GTATTEPSPT
     SLAYVIFTSG STGKPKGVMV EHRSVIRLVR KESNSMSKMS SRARVAHLTN IAFDVSAWEV
     YATLLNGGTL VCVDYFTSFD AKALGLLFER EQITAAMITP TLLKQCITIV PEALRKLSVL
     YTGGDRFDRR DAIATKALVK GPVYNAWGPT ETTIVSTIYE LADDDQFTNG VPIGKAVSNS
     WAYVMDLNQQ LVPVGVMGEA VVIGDGLARG YTDPALDCNR FVHITIDGKR VRAYRTGDRA
     RYRPKDGEIE FFGRMDRQLK IRGHRIEPAE IEHAMLGHND IVDVAIVTRH QDGAGLEMVA
     FVTAHTNKSI ERNEATNQVA GWGDHFESST YAELDTLVKS DVGKDFVGWT NMYDGGAIDQ
     AEMQEWLDDT IQTIVDGQPA GHVFEIGTGT GMIMFGLGKQ GLQSYVGLEP STSATTYVNR
     KIKTAPTVAG KAKVYVGTAM EAAQLNGLHP EVVVINSVAQ YFPTPEYLLE VVGILTQMPG
     VKRLFFGDIR SYATNRKFLA ARALHMLGSN AKKHDIRRKM AELDEFEEEL IVDPSFFTGL
     VSRLPGQVKH VEILPKQMIA TNELSAYRYA AVVHLALPEE QHIAKIEKGA WVDFTATKMD
     RSALVHHLQS SSNAEIVAIS NIPFSKTNFD CHLLASLDED EEHSLDGSAW IKTIHSSAEQ
     CPSLSATDLV EVAKEVGFRV ELSWARQKSQ NGALDAIFHQ YQSPKEGSRV LIQFPTDDQG
     RSMESLTNRP LQRVQSRRIE TQIRERLQAV LPSYMIPARI VVLNEMPVNA NGKVDRKELT
     RRAKVVPRIE TAAERIQPRN EVEAVLCEEF SEVLGVEVGV TDNFFDLGGH SLMATKLAAR
     TGRRLDAKVS VKDVFDHPVL ADLAAAIQRG STPHSAIVTT EYSGPVEQSY AQGRLWFLEQ
     LNFKATWYLL PLAVRIRGPL NIKALTTALH ALEQRHETLR TTFIERDGVG KQAVQPFQPK
     ELEIVDIAAD HQGDYLKVLR DEQTTMFNLA TQPGWRVTLH RVDQNTHNLS IVMHHIISDG
     WSVDVLRHEL RQFYAAALRG QDPLAHISPL PIQYRDFSLW QKQPDQIIEH AKQLEYWTKQ
     LADSSPAELP TDLPRPAVLS GKAGEVALSV KGPLYERLQA FCKTHQTTAF ATLLAAFRAT
     HHRLTGAEDA TIGTPIANRN RPELENLIGF FVNAQCMRIT IDGDETFESL IRQVRATATA
     AIANQDVPFE RIVSTMQSTS RDTSRNPLVQ LMFALHSQQD LGKIQLEGCE TEPIPRAVRT
     RFDLEFHLYQ EQGSLGGIVY FATDLFEPES IEGMVSIFKE ILARALDQPQ TPLALLPLTD
     GLAELRRRGL LEIERPSYPR ESSVVDVFCS QVAASPNATA VKDSISQLTY AQLNEQSDKV
     AAWLHQCNLP TETLVAVLAP RSCQTVVAFL GILKANLAYL PLDVNVPAAR IEAILSEVSG
     HILVLLGSHV SAPKIELADV EFVKIDNTVE HNLPGRIGSA PSATSLAYVI FTSGSTGKPK
     GVKVEHRGIV RLVKESNVVA KMPQAARIAH LSNIAFDAAT WELYAALLNG GTLVCINYLT
     TLDSKALEAV FEQEKIQAAM LPPALLKQYL VNIPAAIGAL EVVLVAGDRF DRRDAAATQA
     LVGAGVYNAY GPTENTTLST IYNVVQGDAN VNGVPIGRPV SNSGAYIMNM NQELVPIGVI
     GELVVVGDGV ARGYTDPALD VNRFVNVTIE GQTMRAYRTG DRARYRPKDA QIEFFGRMDQ
     QIKIRGHRIE PAEVEHALLN NDLLQDAAVI IRKQQNDELE MVAFVEANSN KSIEQEASNQ
     VEDWGAQFES NVYAEIEAID ASAVGNDFMG WTSMYDGSAI DKAEMQEWLD DTMQTILDGR
     PAGRVLEIGT GTGMILFNLG EGLQSYVGLE PSTSAAAFVN RRIQTLPAFA GKAEVHVGTA
     TDISQLQDLR PEVVVINSVA QYFPSPEYLS KVLYALAQIP GVKRLFFGDM RSYAINDQFL
     AARALHNIGS KATKSAIRSK MVDLENSEEE LLVDPTFFTN LATELPEVEH VEILPKRMQA
     TNELSAYRYA AVVHIRDPAR QAQTVHTIDP TAWIDFSASQ MNRTALANLL QNSADAAAIA
     VSNIPYSKTI LARHIVQSLD DDLTDSDDPQ DELEGAAWMS AIRSNIKTCA SLSAFDLAQL
     AQEKGFRVEL SWARQRTHHG ALDAVFHHYK SNQDGGRVLV QFPTDSRPRL SGQLTNQPLQ
     RLQSRRLEAQ IRDQLSALLP SYMIPSLIVM VDEMPLNANG KVDRKALERR ARMVQKVEKP
     ASERVGARNE IEAALCEVFV DLLGTEVSIT DNFFNLGGHS LMATKLAARI SRRLDARISV
     KDVFDYPVLA DLAGAVQRGS TPHNPIVATP YSGPVEQSFA QGRLWFLDQL NAGSLWYIQP
     IAVRVRGSLN IGALTTALNA LEKRHEPLRT TFEEHDGIGV QVVQPHQPKK LRIVDTVANY
     QGDFIRALRK EQQTLFNLAT EPGWRVSLLR IGEDDNILSI VMHHIISDGW SVDILRQDLK
     LFYAAALKSQ EPQVDALPIQ YRDFAFWQKQ PEQVAEHQRQ LDYWIEQLKD SKPAELITDF
     PRPEVLSGTA GIVQLAVDGQ VYEGLRAFCR IHQTTSFVVL LAAFRAAHYR LTGTEDATIG
     SPIANRNRPE LESLIGFFVN TQCMRIMVGE DDTFERLVQQ VRSTTTAAFA NQDVPFERIV
     SSVQSTSRDA SRNPLVQLMF ALHSQQGIGL MELEGVETEP IARDVSTRFD IEFHLYQKEE
     SLHGVVHFAA DLFEPETIQG LVSVFQEILR RGLETPRLPI SILPLDNNIP ELLVGMLDVD
     TPEYPRDSSV VDVFRTQVAA SPDAIAVKDS TSQLTYAQLD EESNKVATWL SQRQLAPETL
     VGVLAPRSCP TIVTFFGILK ASLAYLPLDV NVPSARIEAI LSAVPDHKLV FLGADVPDPE
     APLVNVELVR IDDILRQSIH ASNAGLLANH PLATSLAYVM FTSGSTGKPK GVMVEHRSIV
     RLVKETNLVP AVEAVSSVAH ISNVAFDAAT WEIYAALLNG GTTVCIDHIT VLDPAKLALV
     FSSEKIKAAF FSTALLKQRL YEEPSTITGL DLLYAGGERM RPQDALKTRE LVRGSFCHVY
     GPTENTTFST VYPMGVEERC VNGLPIGRAV SHSGAVIMDA NQRLVPLGVM GELVVTGDGL
     ARGYTDPALN RDRFVEVNIH GQVLRAYRTG DQARYRPKDG QIEFSGRMDR QLKIRGHRIE
     PAEVEHAILS HDDIRNAVVV TRQQEGQDLE MVAFVSTPND QTVERDEARN QVEDWGAQFE
     SNVYAEIEEI DSSAVGNDFM GWTSMYDGTA IDKAEMQEWL DDTMRTLHDG RDPGHVLEVG
     TGTGMILFNL GKGLQSYVGL EPSTSAAAFV NRKIETISSL AGKAKVEIGT ATDVGQLKNL
     RSDLVVINSV AQYFPSPEYL VEAVTALVHI PGVKRLFFGD MRSYAMNKQF LVARALRTLG
     AKANKDDVRR KMVELEEFEE ELLVDPAFFT GLANWLSEVE HVEILPKQMT STNELSSYRY
     AAIVHLRLPG QEAQPVVTVN QDAWVDFGGS KMDRHALLHH LQSSPKAETV AISNIPYSKT
     IYERHVLASL DDDEVEDSLD GSAWLSAVRS TAEQCASLSG VDLVQIAKEA GFRVELSWAR
     QRSQKGGIDA VFHHYESVHD GARVMVKFPT DDQGRALDSL ANRPLQRLQS RRIEVQIRER
     LQAVLPSYMM PVRIVVLDEM PMNANGKVDR KVLTRRAKMI SRVETTAERV GPRNEIEALL
     CEEFAEVLGV EVGINDDFFD LGGHSLMATK LAARSSRRFD AKVSVKDVFD HPILADLAAS
     IQRGSTPHNP ILATQYSGPV EQSFAQGRLW FLEQLNVSST WYLQPIAVRM RGPLKIEALA
     AAFHALEERH ETLRTTFEEH DGIGMQVVQP HRPKELRVID VQAEHDGDYT QALHTEQTTT
     FNLETEPGWR VSVFRLNEDD NILSIVMHHI ISDGWSFDIL RKEIREFYNA ALKGKDPLAQ
     MSPLHIQYRD FSVWQKQLNQ ITEHKRQLDY WTKNLADNTP AELPTDLPRP AVLSGKAGVI
     QLSITGPVYD RLRAFCRVHQ TTLFTVLLTV FRATHYRLTG AEDATIGTPI ANRNRPELEN
     LIGFFVNTQC MRITVEEEDT FETLIHQVRT TTTAAFANQD VPFERIVSAL LPGSRDTSRN
     PLSQIMFAVH SQKNISKIEL DGLESEAISR ATSTRFDLEF HLFQEEKGLG GIVLFAADLF
     EPETIDSLVF VFQEILRQSL ETPKTPIAVL PLTNGIAQLR SMCVLDIEKT AYPQDSSVID
     IFRQQVAARP DATAVTDSTS QLTYAQLDLH SDELASWLRQ KKMAPETLVG VLAPRSCQTI
     VTFLGILKAS LAYLPLDVKV PVARIEAILS SISGQKLILL GQDVPVPEIQ LPDVDVVPIS
     EILGRSVPSR ATDKSLGPLA RNLAYVLFTS GSTGKPKGVM IEHRSIVRLV KETNLISKLP
     NAPRTAHLTN LVFDNSAWEI YSTLLNGGTL VCIDYATVLD SKALETVFKE QRIQTSLMPP
     ALLKECLANM PTMFDDVEVL YALGDRFDKQ DAMKARSIVK TAVYNAYGPT ENTVISTIYE
     IAKDDSFVNG VPIGRSISNS GAFIMDSRQQ LVPVGVLGEL VVSGDGLARG YTDPTLDVNR
     FVEVTVDGQH VRVYRTGDRV RFRPKDGQIE FFSRMDQQVK IRGHRIEPAE VEHVILTNKI
     IRDAAVAIRR PEGQEPEMVA FVTTHENTSI EKQSVEEFAA RIENEVRRWI KTLLPLYMVP
     TQIVVLDRMP VNANGKVDRK ELAQRAQTLQ KSEAGSLPSV RVPPTNDMER ILCEEFADVL
     GVEVGITDNF FDFGGHSLMA TKLAARISRR VNARVSVKSV FDHPVLVDLA STIKQDSIMH
     KPIPQTAYTG PVEQSFAQGR LWFLDQLNFG ASWYLMPLAL RLQGSLHVKS LTTALFALEQ
     RHETLRTTFE EQDGVGIQIV HPANKKDLRI LDVSKEQNSD YAKVLHKERT IPIDLTSEPG
     WRVSLIRLGE DDHILSIVMH HIISDGWSVD VLRQELKQFY TAALKGQDPL AQIDALPIQY
     RDFSLWQKLP DQVAEHQRQL EYWAEQLADN TPAELLTDLP RPDVLSGKAG AVQLTIDGPV
     FDQLQAFCRA HQTTMFTVLL AVFRTTHYRL TGATDATIGT PIANRNRPEL ERLVGFFVNT
     QCIRITVDVE DTFEALVRQV HSTSTTAFAN QDVPFERIVS TILPGSRDAS RNPLAQLMFA
     VHSQRDISKF QLEGLDTKPI PTAASTRFDI EFHMFQQAER LSGRVLFAED LFELETIQGM
     VVIFKEILRR GLETPQTPLA VLPLTDGLAH LRSQGLLEIE RPEYPRDSSM IDVFRAQVAA
     CPDAIAVKDS TSQLTYSQLD DQSDKITAWL LQRKIPAESL VAVYAPRTCQ TIITFFGILK
     ANLAYLPLDI NVPAARIEAI LSTISGHKLV LLGSQVSAPA VQLKDVEYVW IDEAMAETVR
     TCTSPEPSAT SLAYVIFTSG STGLPKGVKV EHRGVVRLVK QSNVVAKMPQ AARVAHLSNI
     AFDAATWEIY AALLNGGSLI CIDYFTTLDS KELEAVFARE KIQAAMLPPA LLKQCLVNIP
     ATISALDVVL AAGDRFDRRD AAATQALVGG CVYNAYGPTE NTTLSTIYNV VKGDANVNGV
     PIGRPVSNSG AYIMDPNQQL VPKGVMGELI VVGDGVARGY TDPALDVNRF IEIAIDGDQA
     VRAYRTGDRA RYRPKDGQIE FFGRMDQQIK IRGHRIEPAE VEHAVLDNSM VQDAAVITRK
     QDQELEMIAF VTTRSDKEID NDEASNQVED WGNQFESNIY AEIEEIDSSA IGKDFMGWTS
     MYDGSAIDKD EMQEWLDDTM STLLDGRQPG HVLEIGTGTG MILFNLAERM GLKSYVGLDP
     SEKATSFVKQ AIKSRPSLAG KAEVHVGTAT DVARMRDLHP EVVVINSVAQ YFPSPEYLAD
     VVGALVRIPG VKRLFFGDIR SYATNNHFLA ARALHKLGEK ATRDTVRSKM AELEGYEEEL
     LVDPTFFTSL TAKLHGQVEH VEILPKRMQA TNELSAYRYA AIVYIRDPKR AQTVQTVKSD
     AWVDFSTSQM DRSVLVSLLQ SSDAEAIAVS NIPYSKTIVA RHIVESLSAE DSQEMLDGPA
     WISAVRSSAE QCASLSAIDL VQVAKENGFR VELSCARQRS HNGAIDAVFH HYKPAQEGSR
     VLLQFPTDNH IRAGSLTNRP LQRLESRRVE TKLKEHLFSV LPSYMIPSHI VMVDQMPLNA
     NGKVDRKALA QRAEAVLKIE KPASERVSAR NEVEAVLCEE FTDVLGVEVG ITDNFFDLGG
     HSLMATKLAA RISKHLDARV SVKDVFDYPV VADLAASIER NSIPHNPIPS TNYSGPVEQS
     FAQGRLWFLD QLNMGVSELY LMPLALRLRG PLRVDAFAAA VSALEARHET LRTTFMDHDG
     VGMQVILPSN SKKLRVIDAS ENDYIDILRQ ERTAPFNLTT EPGFRIALLQ LGQTDFILSI
     VMHHIIYDGW SIDVLCRELG RFYSAALQGQ DPLAQVSPLP IQYRDFSIWQ KRPEQVAEHE
     RQLQYWTEQL ADSSPAELLT DLPRPLVPTG KAGIVQLTIE GAVYERLRAF CRVHQTTSFA
     VLLAAFRATH YRLTGAEDAT IGSPIANRNR PELESLIGFF VNTQCIRVTI REDDTFDKLV
     QQVRATTTAA QVNQDVPFER IVSALMPGSR DTSRNPLVQL SFALHSQHDL GRIDLQDLTG
     EALPTPVFTR LDVEFHLFQQ AEKFGGSVLF ATDLFEPETI QGLVSVFQEV LRRGLEQPQT
     PIAVLPLDNA SEDLRSMGLL QMERTNYPRD SSVVDVFRDQ VAANPRAIAV KDSVLELTYA
     QLDEKSDQLA AWLCQHNIPA ETIVGVLAPR SCETIIAFLG ILKANLAYLP LDDNVPAARI
     ETILSAVPGH TLVLLGSHVA APSIGLADAE FVNINHTLGH SLQLNSTCAK LQPSATSLAY
     VIFTSGSTGK PKGVMIEHRS IVRLVKNSNT LAKLPRAARV AHQFNLAFDA ANYEIYGTLL
     NGGALICVDY STLLDIDALV AMFKREKITA SSLSPGLLKQ CVNSAPEMLK ALQVIYTGGD
     RLDGRDAIEL QALVPGGVYN MYGPTENTVI STLYNLGDKH SYVNGVPIGT TVSNSGAYVM
     DALQQLVPVG VMGELVVTGD GLARGYTDPE LDRNRFIKVN IDGQVVRAYR TGDRVRYRRI
     DGQLEFFGRM DQQIKIRGFR IETAEVENAM LSHSAVRNAA VVVPTQDIQE KGMIGFVVIE
     NNTPKNEESK EEHLLQTELA ILNRMKSILP PYMLPSRIII LDQMPSNFNG KVDRKELDRM
     AQSVPRQKTT AGRIVPRNEL EASLCKEFAE VLGVEVGITD NFFDLGGHSL LATKLAARIS
     RRLDTRVSVK DVFDQPVPAD LALKVSSYIS QGHAMDNGTL STTNSIPFQL LHFEDSQKFI
     DRDIVPQLAH QSAKIVDVYP VTWIQKHFLV DPATGLPRTP SLFFVDFPAN ADCDKICNAS
     RSLIQLFDIF RTVFVQAAGN FYQVVLEELD IPISVIETED ISTATRVLKE QDQQNPLQFG
     QGFLRFAVVK TRSAVRLVLR ISHCLYDGLS FEHVVQSLHA LYNGDRIPTQ PKFVQYVQHL
     TDSRKEGYDF WLSVLEESSM TVVETGRRAQ QLSSPEGAWF VEKIIKAVIP ANSDGITQAT
     VFTTASTILL ARMTGSSDIT FSRLVSGRQS LPINDQHIVG PCTNIVPVRI RMTDGTNARE
     LLGMVQDQYI DSLPFETLGF DDIKENCTKW PASTTNYGCC STFQNFEMQP QSQVQDERVR
     LAGLTNFKDA ELLNGATATN KRVLDDVPMH EIDMIGIPEP DGLHVRVVLT ASRQIFEEEV
     VDRMHEEFCD IILGLNKILQ K
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024